The pharmaceutical industry's demand for high-quality intermediates is constantly growing, driven by the development of innovative therapies. 4-Chloro-7-methoxyquinoline-6-carboxamide (CAS: 417721-36-9) is a prime example of such a critical compound, serving as a fundamental building block in the synthesis of Lenvatinib Mesylate. This article delves into the key specifications, chemical properties, and manufacturing insights crucial for businesses looking to buy this essential pharmaceutical intermediate.

As a supplier and manufacturer, we understand the rigorous standards required for pharmaceutical intermediates. 4-Chloro-7-methoxyquinoline-6-carboxamide is characterized by its molecular formula C11H9ClN2O2 and a molecular weight of 236.65 g/mol. Typically supplied as an off-white to light yellow solid powder, its purity is a paramount specification, with HPLC assays usually requiring a minimum of 98.0% or higher. Impurity profiling is also a critical aspect, as even trace impurities can affect the final API's efficacy and safety. Manufacturers must implement stringent quality control processes to ensure consistency and adherence to specifications.

The primary application of this compound is its role as a direct precursor in the chemical synthesis of Lenvatinib Mesylate, an FDA-approved drug for treating several types of cancer, including thyroid, liver, and kidney cancers. The specific chemical structure of 4-Chloro-7-methoxyquinoline-6-carboxamide is designed to undergo further transformations to yield the final Lenvatinib molecule. Therefore, ensuring a reliable and consistent supply is vital for pharmaceutical companies engaged in Lenvatinib production. When seeking to purchase this intermediate, partnering with experienced manufacturers is highly recommended.

Storage conditions are also critical for maintaining the integrity of this chemical. Manufacturers typically advise storing it in sealed containers, protected from light and moisture, in a cool and dry environment, often refrigerated (2-8°C). These conditions help prevent degradation and preserve the compound's reactivity and purity, ensuring that it remains suitable for complex pharmaceutical synthesis. Buyers should always inquire about the recommended storage and handling procedures to ensure optimal product quality.

For companies looking to procure 4-Chloro-7-methoxyquinoline-6-carboxamide, understanding the supplier's manufacturing capacity, quality management systems, and responsiveness to inquiries is essential. Factors such as competitive pricing, availability of bulk quantities, and efficient logistics are also key considerations. As a dedicated manufacturer and supplier in China, we are committed to providing high-quality intermediates that meet the rigorous demands of the pharmaceutical industry. We encourage you to contact us for a quote or to discuss your specific needs for this vital Lenvatinib intermediate.